The Efficacy and Safety of Hepatitis A Vaccine in Children and Young Adults With an Autoinflammatory Diseases on Canakinumab and Tocilizumab Treatments: A Prospective Observational Controlled Study
Hepatitis A vaccine is effective and safe in children with autoinflammatory diseases on biologic therapy. Long-term follow-up data, including larger patient cohorts, are needed to draw a solid conclusion about the safety of hepatitis A vaccine in patients receiving canakinumab and tocilizumab therapy.
Authors
- Pelin Yüksel Mayda (ORCID: https://orcid.org/0000-0002-6998-5421)
- Nergis Akay (ORCID: https://orcid.org/0000-0001-6102-4055)
- Mehmet Yıldız (ORCID: https://orcid.org/0000-0002-7834-4909)
- Aybüke Gunalp (ORCID: https://orcid.org/0000-0003-0137-0460)
- Amra Adrovic (ORCID: https://orcid.org/0000-0002-2400-6955)
- Fatih Haşlak (ORCID: https://orcid.org/0000-0002-6963-9668)
- Esma Aslan (ORCID: https://orcid.org/0000-0002-7554-3320)
- Elif Kılıç Könte (ORCID: https://orcid.org/0000-0002-8174-5308)
- Kenan Barut (ORCID: https://orcid.org/0000-0001-8459-2872)
- Özgür Kasapçopur (ORCID: https://orcid.org/0000-0002-1125-7720)
- Bekir Sami Kocazeybek (ORCID: https://orcid.org/0000-0003-1072-3846)
- Sezgin Şahin (ORCID: https://orcid.org/0000-0002-5365-3457)
- Ümit Gül (ORCID: https://orcid.org/0000-0002-1282-8273)
- Ömer Faruk Beșer (ORCID: https://orcid.org/0000-0001-8241-9531)
Institutions
- Istanbul University-Cerrahpaşa (TR)
- Kocaeli Üniversitesi (TR)
Publication Details
- Journal
- International Journal of Rheumatic Diseases
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1111/1756-185x.70196
- Citations
- 1
- Primary Topic
- Hepatitis Viruses Studies and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 1.32